Vault-13

Prosight Management, LP

DALLAS, TX · CIK 1617201 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$123.5m reported value -13.1% vs Q1 2022
23positions
76.8%in top 10
7 new 10 added 6 reduced 14 sold out vs Q1 2022

Options: 1 call positions ($3.5m notional), 0 put positions (— notional) – listed below, not included above.

Also in the report of:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GALAPAGOS NV SPON ADR LKFT LKFT 369,000 $20.6m16.68% 16.68% ReducedShares held: Q3 2021 250.7k, Q4 2021 345.9k, Q1 2022 374.0k, Q2 2022 369.0k -5.0k -5,000 -1.3%
2 PROTHENA CORP PLC SHS PRTA PRTA 550,000 $14.9m12.10% 12.10% ReducedShares held: Q3 2021 323.3k, Q4 2021 441.0k, Q1 2022 566.5k, Q2 2022 550.0k -16.5k -16,538 -2.9%
3 KEZAR LIFE SCIENCES INC COM COM 1,262,691 $10.4m8.46% 8.46% AddedShares held: Q3 2021 630.0k, Q4 2021 360.0k, Q1 2022 300.0k, Q2 2022 1.3m +962.7k +962,691 320.9%
4 ALBIREO PHARMA INC COM BIOD BIOD 467,795 $9.3m7.52% 7.52% ReducedShares held: Q3 2021 445.0k, Q4 2021 514.1k, Q1 2022 480.0k, Q2 2022 467.8k -12.2k -12,205 -2.5%
5 KALVISTA PHARMACEUTICALS INC COM KALV KALV 820,752 $8.1m6.54% 6.54% AddedShares held: Q3 2021 257.4k, Q4 2021 409.6k, Q1 2022 589.3k, Q2 2022 820.8k +231.5k +231,482 39.3%
6 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,985,883 $7.9m6.42% 6.42% AddedShares held: Q3 2021 735.0k, Q4 2021 1.2m, Q1 2022 1.4m, Q2 2022 2.0m +585.6k +585,644 41.8%
7 MEIRAGTX HLDGS PLC COM MGTX MGTX 986,218 $7.5m6.05% 6.05% AddedShares held: Q3 2021 291.1k, Q4 2021 0, Q1 2022 380.7k, Q2 2022 986.2k +605.5k +605,518 159.1%
8 CHARLES RIV LABS INTL INC COM CRL CRL 27,500 $5.9m4.77% 4.77% ReducedShares held: Q3 2021 0, Q4 2021 15.5k, Q1 2022 31.5k, Q2 2022 27.5k -4.0k -4,000 -12.7%
9 1LIFE HEALTHCARE INC COM COM 725,000 $5.7m4.60% 4.60% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 725.0k
10 QUIDELORTHO CORP COM QDEL QDEL 46,576 $4.5m3.67% 3.67% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 46.6k
11 SHATTUCK LABS INC COM STTK STTK 1,020,000 $4.1m3.35% 3.35% AddedShares held: Q3 2021 169.2k, Q4 2021 260.2k, Q1 2022 798.7k, Q2 2022 1.0m +221.3k +221,282 27.7%
12 CUE BIOPHARMA INC COM COM 1,655,477 $4.1m3.34% 3.34% AddedShares held: Q3 2021 655.2k, Q4 2021 829.0k, Q1 2022 1.5m, Q2 2022 1.7m +145.2k +145,195 9.6%
13 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 276,802 $3.8m3.09% 3.09% AddedShares held: Q3 2021 0, Q4 2021 128.7k, Q1 2022 203.3k, Q2 2022 276.8k +73.5k +73,534 36.2%
14 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 101,847 $3.3m2.64% 2.64% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 101.8k
15 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 161,527 $3.1m2.55% 2.55% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 73.9k, Q2 2022 161.5k +87.6k +87,597 118.5%
16 TENET HEALTHCARE CORP COM NEW THC THC 50,700 $2.7m2.16% 2.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 50.7k
17 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 176,680 $1.9m1.51% 1.51% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 176.7k
18 ARS PHARMACEUTICALS INC COM SPRY SPRY 341,108 $1.4m1.17% 1.17% AddedShares held: Q3 2021 0, Q4 2021 53.8k, Q1 2022 325.4k, Q2 2022 341.1k +15.7k +15,743 4.8%
19 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,707,509 $1.3m1.08% 1.08% AddedShares held: Q3 2021 282.3k, Q4 2021 356.6k, Q1 2022 599.3k, Q2 2022 1.7m +1.1m +1,108,221 184.9%
20 ARDELYX INC COM ARDX ARDX 2,163,520 $1.3m1.03% 1.03% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.2m
21 INMODE LTD SHS INMD INMD 45,000 $1.0m0.82% 0.82% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 45.0k -5.0k -5,000 -10.0%
22 APOLLO ENDOSURGERY INC COM COM 90,176 $329.0k0.27% 0.27% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 90.2k
23 COGNITION THERAPEUTICS INC COM CGTX CGTX 120,198 $254.0k0.21% 0.21% ReducedShares held: Q3 2021 0, Q4 2021 302.0k, Q1 2022 240.1k, Q2 2022 120.2k -119.9k -119,882 -49.9%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
CONVEY HEALTH SOLUTIONS HLDG 748,134 $4.9m748.1k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 22,704 $3.7m22.7k shares
AGILON HEALTH INC 140,000 $3.5m140.0k shares
QUIDEL CORP QDEL QDEL 25,675 $2.9m25.7k shares
ENCOMPASS HEALTH CORP EHC EHC 39,900 $2.8m39.9k shares
OSCAR HEALTH INC OSCR OSCR 237,500 $2.4m237.5k shares
ACCOLADE INC ACCD ACCD 124,393 $2.2m124.4k shares
SELECT MED HLDGS CORP SEM SEM 90,788 $2.2m90.8k shares
CRISPR THERAPEUTICS AG CRSP CRSP 34,000 $2.1m34.0k shares
GLOBUS MED INC GMED GMED 18,000 $1.3m18.0k shares
NEOGENOMICS INC NEO NEO 63,524 $772.0k63.5k shares
SIO GENE THERAPIES INC AXON AXON 670,300 $449.0k670.3k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 20,000 $333.0k20.0k shares
CYMABAY THERAPEUTICS INC CBAY CBAY 93,923 $292.0k93.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
1LIFE HEALTHCARE INC Call Call 440,000 $3.5m440.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
SHATTUCK LABS INC STTK · 13G · filed 2025-11-13 STTK 9.9%≈ $45.4m 13G 2025-11-13
ADC THERAPEUTICS SA ADCT · 13G · filed 2026-02-13 ADCT 6.8%≈ $9.1m +1.0 pts 13G 2026-02-13
JANUX THERAPEUTICS INC JANX · 13G · filed 2026-02-06 JANX 5.3%≈ $48.5m new 13G 2026-02-06